Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced its intention to offer, subject to market and other conditions, $400 million aggregate principal amount of convertible senior notes due 2032 ...

Travere Therapeutics recently reported quarterly results showing higher revenue and a smaller net loss than the prior year, alongside mostly positive Wall Street analyst commentary. At the same time, ...

(TVTX) on Monday reported a loss of $37.1 million in its first quarter.

Travere (TVTX) delivered earnings and revenue surprises of -30.74% and -1.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

FILSPARI achieved record 993 new PSFs for IgAN in the U.S. in the first quarter; U.S. net product sales grew 88% year over ...

Travere Therapeutics Inc. (NASDAQ:TVTX) reported first quarter results that fell short of Wall Street expectations, with both earnings and revenue missing analyst ...

Travere Therapeutics TVTX posted a profit for the first quarter on Monday. The company reported quarterly earnings of 5 cents ...

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Over the last 7 days, the United States market has remained flat, yet it has seen a significant rise of 28% over the past year, with earnings projected to grow by 16% annually in the coming years. In ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the first quarter ended March 31, 2026, ...

The kidney community needs lawmakers to hear their voices and consider the impact of legislative and policy decisions on the people living with this chronic illness,” said LaVarne A. Burton, AKF ...

Waystar , a provider of leading healthcare payment software, today announced it has been named to the TIME100 Most Influential Companies list and recognized as the TIME Impact in AI award winner for ...